skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 (Code C79794)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593

Definition: An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation.

Display Name: VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593

Label: VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593

NCI Thesaurus Code: C79794 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2703162  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593

External Source Codes: 
PDQ Closed Trial Search ID 618858
PDQ Open Trial Search ID 618858 (check for NCI PDQ open clinical trial info)
UMLS CUI C2703162

Other Properties:
     Name Value (qualifiers indented underneath)
code C79794
Contributing_Source CTRP
Legacy_Concept_Name VEGFR_PDGFR_Tyrosine_Kinase_Inhibitor_TAK-593
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom